Evidence map›Paper›PMID 33540653›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Eliza Depoorter, Evelien De Canck, Tom Coenye, Peter Vandamme

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. The Crucial Role of LTTR_0390 inJournal of agricultural and food chemistry · 2026
    Article
  4. Article
  5. Biological control ofFrontiers in microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in plant science · 2023
    Article
  12. Article
  13. Metabolic Footprints ofMicroorganisms · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eliza DepoorterLaboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0003-1206-7256
Evelien De CanckLaboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, 9000 Ghent, Belgium.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Department of Pharmaceutical Analysis, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-6407-0601
Peter VandammeLaboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-5581-7937
Ghent University · BE

Funding

Fonds Wetenschappelijk Onderzoek 1119517NFonds Wetenschappelijk Onderzoek 1119519NIndustrieel Onderzoeksfonds Universiteit Gent F2015_IOF_ConcepTT_142Industrieel Onderzoeksfonds Universiteit Gent F2017_IOF_StarTT_208
6 · The paper itself

Abstract

Antimicrobial resistance in Gram-negative pathogens represents a global threat to human health. This study determines the antimicrobial potential of a taxonomically and geographically diverse collection of 263

Indexed as

antimicrobial activityBurkholderiaESKAPE pathogensnatural productsnovel molecules

Identifiers

PMID33540653
PMCPMC7912996
OpenAlexW3129038928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.